Filing Details

Accession Number:
0001209191-19-055288
Form Type:
4
Zero Holdings:
No
Publication Time:
2019-11-05 17:23:36
Reporting Period:
2019-11-01
Accepted Time:
2019-11-05 17:23:36
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
879169 Incyte Corp INCY Services-Commercial Physical & Biological Research (8731) 943136539
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1624033 Yao Wenqing 1801 Augustine Cut-Off
Wilmington DE 19803
Evp, Head Of Discovery Chem No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2019-11-01 7,960 $18.32 103,268 No 4 M Direct
Common Stock Disposition 2019-11-01 7,960 $85.00 95,308 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Non-Qualified Stock Option (right to buy) Disposition 2019-11-01 7,960 $0.00 7,960 $18.32
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
52,542 2020-02-08 No 4 M Direct
Footnotes
  1. This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by reporting person.
  2. This includes an aggregate of 63,951 shares of common stock issuable pursuant to previously reported restricted stock units and earnedperformance stock units that have not vested.
  3. Beginning February 9, 2013, options become exercisable in 25 installments, with the first 33.33% vesting after one year and the remainder vesting monthly over two years